Among CBB, the percentage of women with breast or ovarian cancer who have HBOC is variable: the Bahamas, 24%, with a pathogenic variant in BRCA1, BRCA2 or RAD51C; Trinidad and Tobago, 12%; and Jamaica, 3% (27–30). Here, RAD51C is linked to ovarian carcinoma.